What Is IGF-1 LR3?
IGF-1 LR3 (Long Arg3 IGF-1) is a synthetic analogue of insulin-like growth factor 1 (IGF-1) — an 83-amino acid polypeptide with a molecular weight of approximately 9,111 Da. It was engineered with two key modifications to the native IGF-1 sequence: substitution of arginine for glutamic acid at position 3 (Arg3), and addition of a 13-amino acid N-terminal extension peptide. These modifications dramatically extend the compound’s plasma half-life and reduce its binding affinity for IGF-binding proteins (IGFBPs), making it a more potent and longer-acting research tool than native IGF-1.
IGF-1 is one of the most important growth factors in vertebrate biology — mediating many of the anabolic, proliferative, and survival-promoting effects of growth hormone while also having independent regulatory functions in metabolism, tissue development, and cellular aging. IGF-1 LR3 provides researchers with a pharmacologically enhanced tool for investigating IGF-1 receptor signaling and its downstream biological effects.
The IGF-1 Axis: Essential Context
Understanding IGF-1 LR3 requires understanding the growth hormone/IGF-1 axis. Growth hormone (GH), secreted by the anterior pituitary under stimulation from GHRH (as studied through Tesamorelin, CJC-1295, and Sermorelin), acts on the liver and peripheral tissues to stimulate IGF-1 production. IGF-1 then mediates many of GH’s anabolic and growth-promoting effects through the IGF-1 receptor (IGF-1R) — a tyrosine kinase receptor expressed in virtually all tissues.
IGF-1 LR3 allows researchers to study IGF-1 receptor signaling and downstream effects independently of GH axis stimulation, providing a mechanistically distinct tool from GHRH analogues and growth hormone secretagogues like Ipamorelin.
Key Modifications and Their Research Significance
Arg3 Substitution
The substitution of arginine for glutamic acid at position 3 dramatically reduces IGF-1 LR3’s binding affinity for IGF-binding proteins — particularly IGFBP-3, which normally sequesters approximately 80% of circulating IGF-1 in a biologically inactive ternary complex. By reducing IGFBP binding, IGF-1 LR3 has a much higher proportion of free, biologically active peptide available to interact with IGF-1 receptors. This translates to dramatically enhanced potency compared to native IGF-1 on a molar basis.
N-Terminal Extension
The 13-amino acid N-terminal extension serves two purposes: it further reduces IGFBP binding affinity, and it extends the compound’s plasma half-life from approximately 10-12 minutes (native IGF-1) to approximately 20-30 hours. This extended half-life allows for research designs requiring sustained IGF-1 receptor stimulation rather than the transient pulses produced by native IGF-1.
Mechanism of Action
IGF-1 Receptor Binding and Activation
IGF-1 LR3 binds to and activates the IGF-1 receptor (IGF-1R) with high affinity — similar to native IGF-1. IGF-1R activation triggers autophosphorylation of the receptor’s intracellular tyrosine kinase domain, initiating downstream signaling cascades including the PI3K-AKT-mTOR pathway and the RAS-MAPK-ERK pathway. These pathways regulate cell survival, proliferation, protein synthesis, glucose metabolism, and differentiation.
PI3K-AKT-mTOR Signaling
The PI3K-AKT-mTOR pathway is perhaps the most important downstream effector of IGF-1R activation. This pathway promotes cell survival by inhibiting pro-apoptotic factors, stimulates protein synthesis through mTORC1 activation and ribosome biogenesis, enhances glucose uptake through GLUT4 translocation, and drives cellular growth and proliferation. Research using IGF-1 LR3 extensively employs this pathway as a primary outcome measure.
MAPK-ERK Signaling
The RAS-MAPK-ERK cascade, also activated downstream of IGF-1R, regulates cell proliferation, differentiation, and gene expression. Research has examined IGF-1 LR3’s effects on ERK phosphorylation, cell cycle progression, and proliferative responses in multiple cell types.
Insulin Receptor Cross-Reactivity
IGF-1 LR3 has moderate binding affinity for the insulin receptor — a structural homologue of IGF-1R — which is relevant for metabolic research designs. Researchers investigating IGF-1 effects on glucose metabolism should account for potential insulin receptor-mediated effects, though IGF-1 LR3’s affinity for the insulin receptor is substantially lower than for IGF-1R.
Research Applications
Muscle Biology and Protein Synthesis Research
IGF-1 LR3 is one of the most widely used research tools in skeletal muscle biology. Research has examined its effects on myoblast proliferation and differentiation, satellite cell activation, myotube formation, muscle protein synthesis rates (through mTOR-S6K1 signaling), and atrophy prevention in denervation and disuse models. Its extended half-life and enhanced potency make it particularly useful for in vitro muscle biology studies where sustained IGF-1R stimulation is required.
Cell Proliferation and Survival Research
IGF-1R signaling is a major pro-survival and proliferative pathway in virtually all cell types. Research using IGF-1 LR3 has examined cell cycle progression, apoptosis resistance, and proliferative responses in numerous cell models — from primary neurons to cardiomyocytes to epithelial cells. The compound is commonly used as a positive control for IGF-1R-dependent proliferation in cell culture experiments.
Cancer Biology Research
The IGF-1R pathway is one of the most frequently dysregulated signaling systems in human cancer, where it drives tumor cell survival, proliferation, and resistance to therapy. IGF-1 LR3 is extensively used in cancer biology research as a tool for activating the IGF-1R pathway in tumor cell lines and animal models, enabling investigation of downstream oncogenic signaling, drug resistance mechanisms, and the effects of IGF-1R inhibitors.
Metabolic Research
IGF-1 has important roles in glucose and lipid metabolism — it enhances insulin sensitivity, promotes glucose uptake in peripheral tissues, and influences hepatic glucose production. Research using IGF-1 LR3 has investigated these metabolic effects, particularly in models of insulin resistance and metabolic syndrome. Its extended half-life makes it useful for metabolic studies requiring sustained IGF-1R stimulation.
Neurological Research
IGF-1 receptors are expressed throughout the nervous system where they play roles in neuronal survival, synaptic plasticity, and neuroprotection. Research has used IGF-1 LR3 to investigate IGF-1R-dependent neuroprotection against excitotoxicity and oxidative stress, neuronal proliferation and differentiation, and the role of IGF-1 signaling in neurodegenerative disease models.
GH Axis Research
Because IGF-1 mediates many of GH’s biological effects, IGF-1 LR3 is frequently used in GH axis research to determine which biological outcomes of GH stimulation are IGF-1-mediated versus direct GH receptor-mediated effects. Research designs comparing GHRH-stimulated GH elevation (via CJC-1295 + Ipamorelin) with direct IGF-1R stimulation (via IGF-1 LR3) help dissect the complex biology of the somatotropic axis.
IGF-1 LR3 in the AminoForge GH Axis Research Toolkit
For comprehensive GH axis and growth factor research, IGF-1 LR3 pairs naturally with the full range of GH-axis compounds at AminoForge. Tesamorelin and CJC-1295 No DAC stimulate endogenous GH and downstream IGF-1 production through GHRH receptor pathways. Ipamorelin provides complementary GH secretagogue activity through the ghrelin receptor. AOD-9604 and Fragment 176-191 allow investigation of the IGF-1-independent lipolytic effects of the GH C-terminal fragment. Together, these compounds provide a complete toolkit for systematic GH axis research.
Shop IGF-1 LR3 at AminoForge — ≥99% purity, third-party COA verified, Ships within 48 hours.
Formulation and Storage
IGF-1 LR3 is available as a lyophilized powder. At approximately 9,111 Da it is one of the larger research peptides in the AminoForge catalog and requires careful handling. Lyophilized powder should be stored at -20°C and protected from freeze-thaw cycles. Reconstituted solutions should be stored at 2–8°C, protected from light, and used promptly to minimize degradation.
Acetic acid water (0.1% acetic acid) is the preferred reconstitution vehicle for IGF-1 LR3 — bacteriostatic water can be used but acetic acid solution better maintains stability. Research-grade purity should be verified at ≥99% by HPLC with mass spectrometry confirmation of the 9,111 Da molecular weight.
IGF-1 LR3 receptor binding and biological activity research
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.